• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Telenor to acquire majority stake in DNA, has sights on total ownership

Share:

April 15, 2019

Telenor Group is to acquire 54% of Finnish telecom operator DNA for a total of €1.5 billion.

The company says the move will give it a strong position across fixed and mobile, and strengthen its position in the Nordic region.

Telenor has entered into separate agreements with DNA’s two largest shareholders, Finda Telecoms Oy and PHP Holding Oy, which hold 28.3% and 25.8% of the shares in the company, respectively.

Subject to regulatory approvals, Telenor expects the transaction to be completed during the third quarter of 2019 and then plans to bid for the remaining shares in DNA.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

DNA

Helsinki-based DNA is the third-largest mobile operator in Finland, with 2.9 million subscribers and 28% market share. Over the past three years, DNA has increased its mobile service revenues by 9.3% per year. In addition, DNA is the second-largest fixed broadband provider and the largest cable TV provider in Finland.

In 2018, DNA reported revenues of €912 million, EBITDA of €285 million and operating cash flow of €147 million.

Telenor says it sees “solid potential” for DNA to continue to grow and develop, from offering more advanced products and upselling existing customers to strengthening its position in the business segment and leveraging Telenor’s global scale.

“The transaction is expected to generate material synergies within procurement, roaming and best practice sharing,” a statement said.

Sigve Brekke, Chief Executive, Telenor Group, commented “I am very pleased to announce today’s transaction and our entry into Finland, the fastest growing mobile market in Europe. DNA is an exciting addition to Telenor Group, and a natural complement to our existing operations in the Nordic region.”

Date: April 15, 2019

Source: Mobile Europe

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • In-depth: Bringing Innovation to Places That Need It MostIn-depth: Bringing Innovation to Places That Need It Most
  • Japanese Medical AI Startup Ubie Snaps up $26M in Series C FundingJapanese Medical AI Startup Ubie Snaps up $26M in Series C Funding
  • Medical Devices Pose Cyber Security And Patient ThreatMedical Devices Pose Cyber Security And Patient Threat
  • GSK completes acquisition of TESARO, an oncology focused biopharmaceutical companyGSK completes acquisition of TESARO, an oncology focused biopharmaceutical company
  • Backed by Johnson & Johnson, Thirty Madison Raises $47M for Direct-to-Consumer Telehealth BrandsBacked by Johnson & Johnson, Thirty Madison Raises $47M for Direct-to-Consumer Telehealth Brands
  • INNIO Completes Carve-out from General Electric and Emerges as Stand-alone Energy CompanyINNIO Completes Carve-out from General Electric and Emerges as Stand-alone Energy Company
  • Healthcare Executives are Investing in Digital Health Tech Without Seeing an ROI.Healthcare Executives are Investing in Digital Health Tech Without Seeing an ROI.
  • COVID-19 Sparks Consumer Fears of Seeking In-Person Medical CareCOVID-19 Sparks Consumer Fears of Seeking In-Person Medical Care

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications